http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4884656-B2

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K2019-3422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K2019-327
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K19-3402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C33-483
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-176
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D309-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-176
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C33-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B53-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-773
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D309-04
filingDate 2004-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2012-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-4884656-B2
titleOfInvention Pyran derivatives containing exocyclic double bonds
abstract Pyran compounds having exocyclic double bonds are new. Pyran compounds of formula (I) having exocyclic double bonds are new. [Image] a-e : 0 or 1; W : -CH 2- or -C(=O)-; R 11>H, 1-15 C alkyl optionally substituted by halo or CN and optionally having at least one CH 2group replaced by -Ctriple boundC-, -CH=CH-, -O-, -S-, or -C(O)-O- such that heteroatoms are not directly bonded to each other; R 1>2>H, halo, -CN, -NCS, -O-aralkyl or 1-15 C alkyl optionally substituted by halo or CN and optionally having at least one CH 2group replaced by -Ctriple boundC-, -CH=CH-, -O-, -S-, or -C(O)-O- such that heteroatoms are not directly bonded to each other; Z 1>1>single bond, -CH 2-, -CH 2CH 2, -CF 2CH 2, -CH 2CF 2-, -CF 2CF 2-, -CH=CH- or -Ctriple boundC-; Z 1>2>-CH 2-, -CH 2CH 2-, -CF 2CH 2-, -CH 2CF 2- or -CF 2CF 2-; Z 1>3>-Z 1>5>a single bond, -CH 2CH 2-, -CF 2CH 2-, -CH 2CF 2-, -CF 2CF 2-, -CH=CH-, -Ctriple boundC- -CH 2O-, -CF 2O- or -C(O)- or -C(O)-O-; A 11>, A 12>1,4-cyclohexylene or 1,3-dioxane-5,2-diyl; A 13>, A 14>1,3-cyclobutylene, 3,3'-spiro(cyclobutane-1,1'-cyclobutane), 1,4-cyclohexylene, optionally fluorinated 1,4-phenylene, optionally fluorinated tetralin-6,2-diyl or optionally fluorinated naphthalene-2,6-diyl; A 15>as A 13>; or A 15>-R 12>4-hydroxyphenyl (optionally fluorinated), cyclobutanone-3-yl, cyclohexanone-4-yl or a group of formula (i); [Image] R 13>,R 1>4>1-7C alkyl or together form a 2-7C alkylene bridge; or Z 13>[A 13>Z 14>] c[A 14>Z 15>] d[A 15>] eR 12>a group of formula (ii) or (iii); [Image] L 1>7>-L 1>9>H or F. With the provisos that when Z 13>and R 1>2>are directly bonded R 1>2>is aralkyl, alkyl or alkenyl, if Z 1>3>is -C(=O)-O- or -C(=O)- and Z 1>3>is not -CH 2O or -CF 2O-, when Z 1>4>is -C(=O)-O- or -C(=O)- and Z 1>4>is not -CH 2O or -CF 2O-, when Z 1>5>and R 1>2>are directly bonded, R 1>2>= is aralkyl, alkyl or alkenyl when Z 1>5>is -C(=O)-O- or -C(=O)- and Z 1>5>is not -CH 2O- or -CF 2O-. Independent claims are included for: (1) a process for the production of the pyran compound (I) comprising a metathesis reaction of an ethyne compound of formula (II) in the presence of a metathesis catalyst; (2) ethyne compounds of formula (II); and (3) hydroxy alkene compounds of formula (III) [Image] [Image].
priorityDate 2003-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466552871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465260932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466552804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163634264
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467183526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467013028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466258948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468281059
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467183525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466258949

Total number of triples: 39.